XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock and Additional Paid-in Capital
Common Stock and Additional Paid-in Capital
ASU 2020-06 modified retrospective adoption
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
ASU 2020-06 modified retrospective adoption
Noncontrolling Interests
Balance (in shares) at Dec. 31, 2020   170.2          
Balance at beginning of period at Dec. 31, 2020   $ 761   $ (2,446) $ 1,127   $ 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings $ 1,250       1,245   5
Other comprehensive income (loss) $ 67     67      
Issuance of common stock and stock options exercised (in shares)   1.9          
Issuance of common stock and stock options exercised   $ 99          
Share repurchase program (in shares) (2.5) (2.5)          
Share repurchase program         (528)    
Share-based compensation expenses   $ 129          
Dividends paid to noncontrolling interest in subsidiary common stock             (5)
Dividends declared         (494)    
Balance (in shares) at Dec. 31, 2021   169.6          
Balance at end of period at Dec. 31, 2021   $ 989   (2,379) 1,350   17
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings $ 1,367       1,363   4
Other comprehensive income (loss) $ (156)     (156)      
Issuance of common stock and stock options exercised (in shares)   2.6          
Issuance of common stock and stock options exercised   $ 157          
Share repurchase program (in shares) (3.7) (3.7)          
Share repurchase program         (836)    
Share-based compensation expenses   $ 172          
Dividends paid to noncontrolling interest in subsidiary common stock             (6)
Dividends declared         (544)    
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]            
ASU 2020-06 modified retrospective adoption     $ (10)     $ 10  
Balance (in shares) at Dec. 31, 2022   168.5          
Balance at end of period at Dec. 31, 2022 $ 131 $ 1,308   (2,535) 1,343   15
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 1,714       1,709   5
Other comprehensive income (loss) $ (5)     (5)      
Issuance of common stock and stock options exercised (in shares)   1.8          
Issuance of common stock and stock options exercised   $ 104          
Share repurchase program (in shares) (2.9) (2.9)          
Share repurchase program         (808)    
Share-based compensation expenses   $ 212          
Dividends paid to noncontrolling interest in subsidiary common stock             (5)
Dividends declared         (604)    
Balance (in shares) at Dec. 31, 2023   167.4          
Balance at end of period at Dec. 31, 2023 $ 739 $ 1,624   $ (2,540) $ 1,640   $ 15